Biotech · Private company
Arsenal Biosciences, Inc.
Track this companyFree. Adds Arsenal Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AB-2100Phase 2 · Advanced/Metastatic Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AB-3028Phase 2 · Metastatic Castration Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- AB-1015Phase 1 · Carcinoma, Ovarian EpithelialClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 9, 2026ClinicalTrials.gov NCT07285694 · fetched Nov 12, 2026
- AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 26, 2024ClinicalTrials.gov NCT06245915 · fetched Nov 12, 2026
- AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian CancerPHASE1 · TERMINATED · started Nov 29, 2022ClinicalTrials.gov NCT05617755 · fetched Nov 12, 2026